Indian Journal of Medical Research

ORIGINAL ARTICLE
Year
: 2019  |  Volume : 150  |  Issue : 2  |  Page : 194--198

Detection of heterogeneous vancomycin-intermediate Staphylococcus aureus: A preliminary report from south India


Rajesh Amberpet, Sujatha Sistla, Madhan Sugumar, Niveditha Nagasundaram, Meerabai Manoharan, Subhash Chandra Parija 
 Department of Microbiology, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India

Correspondence Address:
Sujatha Sistla
Department of Microbiology, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry 605 006
India

Background & objectives: Although there are reports of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) across the globe, there is a lack of reliable data on hVISA in India. The present study was undertaken to determine the rate of hVISA among the methicillin-resistant Staphylococcus aureus (MRSA) isolates, and to compare the brain heart infusion agar with vancomycin 4 μg/ml (BHIV4) method with population analysis profile-area under the curve (PAP-AUC) method for the detection of hVISA and to study the distribution of mobile genetic element that carries methicillin-resistance gene SCCmec (Staphylococcal cassette chromosome mec) types among these isolates. Methods: BHIV4 and PAP-AUC methods were employed to detect hVISA among 500 clinical isolates of MRSA. SCCmec typing of these isolates was performed by multiplex polymerase chain reaction. The clinical presentation, treatment with vancomycin and outcome was documented for patients with hVISA. Results: The rate of hVISA was 12.4 per cent by PAP-AUC method. Sensitivity, specificity, PPV, NPV and kappa agreement of BHIV4 with PAP-AUC was 58.06, 93.15, 54.55, 94.01 per cent and 0.498, respectively. The isolation of hVISA was significantly (P<0.01) higher in patients admitted to intensive care units and wards than in patients attending the outpatient departments. Only 38 per cent of the patients received vancomycin as therapy. Majority of the hVISA isolates carried SCCmec type V or IV. Interpretation & conclusions: The rate of hVISA isolation in our study was 12.4 per cent. The sensitivity of the BHIV4 screening test was low, and was in moderate agreement with PAP-AUC test. SCCmec type V was the predominant type seen in half of the isolates. More studies need to be done in different parts of the country on a large number of isolates to confirm our findings.


How to cite this article:
Amberpet R, Sistla S, Sugumar M, Nagasundaram N, Manoharan M, Parija SC. Detection of heterogeneous vancomycin-intermediate Staphylococcus aureus: A preliminary report from south India.Indian J Med Res 2019;150:194-198


How to cite this URL:
Amberpet R, Sistla S, Sugumar M, Nagasundaram N, Manoharan M, Parija SC. Detection of heterogeneous vancomycin-intermediate Staphylococcus aureus: A preliminary report from south India. Indian J Med Res [serial online] 2019 [cited 2020 Aug 7 ];150:194-198
Available from: http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2019;volume=150;issue=2;spage=194;epage=198;aulast=Amberpet;type=0